{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "13", "@year": "2019", "@timestamp": "2019-10-13T21:44:47.000047-04:00", "@month": "10"}, "ait:date-sort": {"@day": "01", "@year": "2015", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Social and Administrative Pharmacy Program"}, {"$": "Faculty of Pharmaceutical Science"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "108180929"}, "@dptid": "108180929"}, "author": [{"ce:given-name": "Osot", "preferred-name": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}, "@seq": "1", "ce:initials": "O.", "@_fa": "true", "@type": "auth", "ce:surname": "Nerapusee", "@auid": "37024668000", "ce:indexed-name": "Nerapusee O."}, {"ce:given-name": "Rungpetch", "preferred-name": {"ce:given-name": "Rungpetch", "ce:initials": "R.", "ce:surname": "Sakulbumrungsil", "ce:indexed-name": "Sakulbumrungsil R."}, "@seq": "6", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Sakulbumrungsil", "@auid": "23089392500", "ce:indexed-name": "Sakulbumrungsil R."}]}, {"affiliation": {"country": "United States", "postal-code": "85721", "@afid": "60010065", "@country": "usa", "organization": [{"$": "College of Pharmacy"}, {"$": "University of Arizona"}], "affiliation-id": {"@afid": "60010065", "@dptid": "110239160"}, "state": "AZ", "@dptid": "110239160"}, "author": [{"ce:given-name": "Chanadda", "preferred-name": {"ce:given-name": "Chanadda", "ce:initials": "C.", "ce:surname": "Chinthammit", "ce:indexed-name": "Chinthammit C."}, "@seq": "2", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Chinthammit", "@auid": "55195924000", "ce:indexed-name": "Chinthammit C."}, {"ce:given-name": "Daniel C.", "preferred-name": {"ce:given-name": "Daniel C.", "ce:initials": "D.C.", "ce:surname": "Malone", "ce:indexed-name": "Malone D."}, "@seq": "5", "ce:initials": "D.C.", "@_fa": "true", "@type": "auth", "ce:surname": "Malone", "@auid": "7102595928", "ce:indexed-name": "Malone D.C."}]}, {"affiliation": {"country": "Thailand", "postal-code": "10520", "@afid": "116497145", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Medical Affairs"}, {"$": "Janssen-Cilag"}], "affiliation-id": {"@afid": "116497145"}}, "author": [{"ce:given-name": "Osot", "preferred-name": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}, "@seq": "1", "ce:initials": "O.", "@_fa": "true", "@type": "auth", "ce:surname": "Nerapusee", "@auid": "37024668000", "ce:indexed-name": "Nerapusee O."}, {"ce:given-name": "Chavalit", "preferred-name": {"ce:given-name": "Chavalit", "ce:initials": "C.", "ce:surname": "Romyen", "ce:indexed-name": "Romyen C."}, "@seq": "3", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Romyen", "@auid": "57188648640", "ce:indexed-name": "Romyen C."}]}, {"affiliation": {"country": "Thailand", "postal-code": "50200", "@afid": "60000881", "@country": "tha", "city": "Chiang Mai", "organization": [{"$": "Faculty of Pharmaceutical Science"}, {"$": "Chiang Mai University"}], "affiliation-id": {"@afid": "60000881", "@dptid": "103084190"}, "@dptid": "103084190"}, "author": [{"ce:given-name": "Maneeporn", "preferred-name": {"ce:given-name": "Maneeporn", "ce:initials": "M.", "ce:surname": "Pangjunhom", "ce:indexed-name": "Pangjunhom M."}, "@seq": "4", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Pangjunhom", "@auid": "57188654191", "ce:indexed-name": "Pangjunhom M."}]}], "citation-title": "Long-acting injectable antipsychotics in patients with schizophrenia: Systematic review and mixed treatment meta-analysis", "abstracts": "Long-acting injectable antipsychotics (LAIs) are recommended for schizophrenic patients who cannot adhere to oral medication. We systematically reviewed randomized controlled trials of 6 LAIs available in Thailand including fluphenazine, flupentixol, haloperidol, zuclopenthixol, paliperidone, and risperidone in PubMed/MEDLINE and the Cochrane library (1955-Nov 2013). Inclusion was limited to studies of schizophrenia \u226524 weeks duration published in English. We selected 17 of 1,245 articles including 1,904 patients. The number of patients ranged from 19 to 747 per study (median 54). Mean study duration was 52.3 weeks (24-96 weeks) and median quality score using a Jadad scoring method was 4 (2-5). We applied a Bayesian model with a mixed treatment comparison approach for 3 competing risk outcomes including relapse, and discontinuation because of adverse events or other reasons. Based on the random effect model preferred by a goodness of fit analysis, risperidone had the lowest 52 week probability of relapse (mean \u00b1 SD, 0.26 \u00b1 0.321) followed by paliperidone (0.30 \u00b1 0.314). Zuclopenthixol had the lowest probability of discontinuation because of an adverse event (0.07 \u00b1 0.159) or other reasons (0.26 \u00b1 0.295). Risperidone had the highest probability of preventing relapse (0.35 \u00b1 0.476) or discontinuation for other reasons (0.31 \u00b1 0.461). Zuclopenthixol had the highest probability of preventing discontinuation because of adverse effects (0.31 \u00b1 0.464). All 6 LAIs tended to have a lower risk of relapse compared with placebo. Differences between LAIs preventing any treatment discontinuation or relapse were seen, but limited in our analysis.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Social and Administrative Pharmacy Program"}, {"$": "Faculty of Pharmaceutical Science"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Competing risk outcomes", "@xml:lang": "eng"}, {"$": "Long acting injectable antipsychotics", "@xml:lang": "eng"}, {"$": "Meta-analysis", "@xml:lang": "eng"}, {"$": "Mixed treatment comparison", "@xml:lang": "eng"}]}, "citation-type": {"@code": "re"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "Asian Biomed.", "website": {"ce:e-address": {"$": "http://abm.digitaljournals.org/index.php/abm/article/download/3297/1034", "@type": "email"}}, "@country": "tha", "translated-sourcetitle": {"$": "Asian Biomedicine", "@xml:lang": "eng"}, "issn": [{"$": "1875855X", "@type": "electronic"}, {"$": "19057415", "@type": "print"}], "volisspag": {"voliss": {"@volume": "9", "@issue": "6"}, "pagerange": {"@first": "741", "@last": "750"}}, "@type": "j", "publicationyear": {"@first": "2015"}, "publisher": {"publishername": "Asian Biomedicine", "ce:e-address": {"$": "chulamed@md.chula.ac.th", "@type": "email"}}, "sourcetitle": "Asian Biomedicine", "@srcid": "19300156818", "publicationdate": {"month": "12", "year": "2015", "date-text": "December 2015", "day": "01"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "32", "classification-description": "Psychiatry"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}]}, {"@type": "ASJC", "classification": "1300"}, {"@type": "SUBJABBR", "classification": "BIOC"}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": [{"cas-registry-number": [{"$": "2413-38-9"}, {"$": "2709-56-0"}], "chemical-name": "flupentixol"}, {"cas-registry-number": [{"$": "146-56-5"}, {"$": "69-23-8"}], "chemical-name": "fluphenazine"}, {"cas-registry-number": [{"$": "52-86-8"}, {"$": "1511-16-6"}], "chemical-name": "haloperidol"}, {"cas-registry-number": [{"$": "144598-75-4"}, {"$": "199739-10-1"}], "chemical-name": "paliperidone"}, {"cas-registry-number": "106266-06-2", "chemical-name": "risperidone"}, {"cas-registry-number": "53772-83-1", "chemical-name": "zuclopenthixol"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "22", "@year": "2016", "@timestamp": "BST 16:24:19", "@month": "04"}}, "itemidlist": {"itemid": [{"$": "609473932", "@idtype": "PUI"}, {"$": "648370162", "@idtype": "CAR-ID"}, {"$": "20160271637", "@idtype": "EMBASE"}, {"$": "2016855560", "@idtype": "REAXYSCAR"}, {"$": "84962109840", "@idtype": "SCP"}, {"$": "84962109840", "@idtype": "SGR"}], "ce:doi": "10.5372/1905-7415.0906.446"}}, "tail": {"bibliography": {"@refcount": "46", "reference": [{"ref-fulltext": "National Collaborating Centre for Mental Health (UK). Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (update). National Institute for Health and Clinical Excellence (NICE) Clinical Guidelines, No. 82. Leicester: British Psychological Society; 2009:1-399.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "refd-itemidlist": {"itemid": {"$": "84962065308", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "1", "@last": "399"}}, "ref-text": "National Institute for Health and Clinical Excellence NICE Clinical Guidelines, No. 82, Leicester: British Psychological Society", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "National Collaborating Centre for Mental Health (UK)", "ce:indexed-name": "National Collaborating Centre for Mental Health (UK)"}]}, "ref-sourcetitle": "Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (update)"}}, {"ref-fulltext": "WHO. World Health Organization International Classification of Diseases, 10th ed. Geneva: WHO; 1990.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "1990"}, "refd-itemidlist": {"itemid": {"$": "0003589137", "@idtype": "SGR"}}, "ref-text": "10th ed, Geneva: WHO", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "WHO", "ce:indexed-name": "WHO"}]}, "ref-sourcetitle": "World Health Organization International Classification of Diseases"}}, {"ref-fulltext": "Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "A systematic review of the prevalence of schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "22144432283", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "e141"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Saha", "ce:indexed-name": "Saha S."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Chant", "ce:indexed-name": "Chant D."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Welham", "ce:indexed-name": "Welham J."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "McGrath", "ce:indexed-name": "McGrath J."}]}, "ref-sourcetitle": "PLoS Med."}}, {"ref-fulltext": "Years of lives with disability from mental disorders, Thailand 2004. Thailand International Health Policy Program. Nonthaburi: Ministry of Public Health; 2004, pp. 21. [Online] 2005 [cited 2015 October 30] Available from: http://www.thaibod.net/documents/YLD%20 Mental%20disorders.pdf", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-website": {"ce:e-address": {"$": "http://www.thaibod.net/documents/YLD%20Mental%20disorders.pdf", "@type": "email"}}, "ref-title": {"ref-titletext": "Thailand international health policy program"}, "refd-itemidlist": {"itemid": {"$": "84962077924", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "21"}}, "ref-text": "Online 2005 cited 2015 October 30", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "Years of lives with disability from mental disorders, Thailand 2004", "ce:indexed-name": "Years of lives with disability from mental disorders, Thailand 2004"}]}, "ref-sourcetitle": "Nonthaburi: Ministry of Public Health"}}, {"ref-fulltext": "Phanthunane P, Vos T, Whiteford H, Bertram M, Udomratn P. Schizophrenia in Thailand: prevalence and burden of disease. Popul Health Metr. 2010;8:24.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Schizophrenia in Thailand: Prevalence and burden of disease"}, "refd-itemidlist": {"itemid": {"$": "77955535171", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "24"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Phanthunane", "ce:indexed-name": "Phanthunane P."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Vos", "ce:indexed-name": "Vos T."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Whiteford", "ce:indexed-name": "Whiteford H."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bertram", "ce:indexed-name": "Bertram M."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Udomratn", "ce:indexed-name": "Udomratn P."}]}, "ref-sourcetitle": "Popul Health Metr."}}, {"ref-fulltext": "Tandon RT, Targum SD, Nasrallah HA, Ross R; Treatment Effectiveness in Schizophrenia Consortium. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. J Psychiatr Prac. 2006;12:348-63.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Strategies for maximizing clinical effectiveness in the treatment of schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "33751548088", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "348", "@last": "363"}}, "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "Treatment Effectiveness in Schizophrenia Consortium", "ce:indexed-name": "Treatment Effectiveness in Schizophrenia Consortium"}, {"@seq": "2", "ce:initials": "R.T.", "@_fa": "true", "ce:surname": "Tandon", "ce:indexed-name": "Tandon R.T."}, {"@seq": "3", "ce:initials": "S.D.", "@_fa": "true", "ce:surname": "Targum", "ce:indexed-name": "Targum S.D."}, {"@seq": "4", "ce:initials": "H.A.", "@_fa": "true", "ce:surname": "Nasrallah", "ce:indexed-name": "Nasrallah H.A."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ross", "ce:indexed-name": "Ross R."}]}, "ref-sourcetitle": "J Psychiatr Prac."}}, {"ref-fulltext": "Janicak PG, Davis JM, Preskorn SH, Ayd FJ. Principles and practice of psychopharmacotherapy. Baltimore: Williams and Wilkins; 1993, pp. 592.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "refd-itemidlist": {"itemid": {"$": "0004261490", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "592"}}, "ref-text": "Baltimore: Williams and Wilkins", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.G.", "@_fa": "true", "ce:surname": "Janicak", "ce:indexed-name": "Janicak P.G."}, {"@seq": "2", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Davis", "ce:indexed-name": "Davis J.M."}, {"@seq": "3", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Preskorn", "ce:indexed-name": "Preskorn S.H."}, {"@seq": "4", "ce:initials": "F.J.", "@_fa": "true", "ce:surname": "Ayd", "ce:indexed-name": "Ayd F.J."}]}, "ref-sourcetitle": "Principles and Practice of Psychopharmacotherapy"}}, {"ref-fulltext": "Kane JM, Woerner M, Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. Psychopharmacology. 1985;2:72-8.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "1985"}, "ref-title": {"ref-titletext": "Tardive dyskinesia: Prevalence, incidence, and risk factors"}, "refd-itemidlist": {"itemid": {"$": "0021940818", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "72", "@last": "78"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Kane", "ce:indexed-name": "Kane J.M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Woerner", "ce:indexed-name": "Woerner M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lieberman", "ce:indexed-name": "Lieberman J."}]}, "ref-sourcetitle": "Psychopharmacology"}}, {"ref-fulltext": "Suvisaari JM, Saarni SI, Perala J, Suvisaari J V, Harkanen T, Lonnqvist J, et al. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry. 2007;68:1045-55.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey"}, "refd-itemidlist": {"itemid": {"$": "34548304309", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "1045", "@last": "1055"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Suvisaari", "ce:indexed-name": "Suvisaari J.M."}, {"@seq": "2", "ce:initials": "S.I.", "@_fa": "true", "ce:surname": "Saarni", "ce:indexed-name": "Saarni S.I."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Perala", "ce:indexed-name": "Perala J."}, {"@seq": "4", "ce:initials": "J.V.", "@_fa": "true", "ce:surname": "Suvisaari", "ce:indexed-name": "Suvisaari J.V."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Harkanen", "ce:indexed-name": "Harkanen T."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lonnqvist", "ce:indexed-name": "Lonnqvist J."}], "et-al": null}, "ref-sourcetitle": "J Clin Psychiatry"}}, {"ref-fulltext": "Meaney AM, O'Keane V. Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables. Schizophrenia Res. 2007;93:136-43.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Bone mineral density changes over a year in young females with schizophrenia: Relationship to medication and endocrine variables"}, "refd-itemidlist": {"itemid": {"$": "34249291613", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "93"}, "pagerange": {"@first": "136", "@last": "143"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "ce:surname": "Meaney", "ce:indexed-name": "Meaney A.M."}, {"@seq": "2", "ce:initials": "V.", "@_fa": "true", "ce:surname": "O'Keane", "ce:indexed-name": "O'Keane V."}]}, "ref-sourcetitle": "Schizophrenia Res."}}, {"ref-fulltext": "Disyavanish C, Srisurapanont M, Karnjanathanalers N, Theeramoke V, Kongsakon R, Kittiratanapaibool P, et al. Thai schizophrenia treatment guidelines. In: Sukanit P, Udomrath P, editors. Clinical practice guidelines in psychiatric disorders. Bangkok: Beyond Enterprise; 2001: p. 67-90.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Thai schizophrenia treatment guidelines"}, "refd-itemidlist": {"itemid": {"$": "84962080914", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "67", "@last": "90"}}, "ref-text": "Sukanit P, Udomrath P, editors, Bangkok: Beyond Enterprise", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Disyavanish", "ce:indexed-name": "Disyavanish C."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Srisurapanont", "ce:indexed-name": "Srisurapanont M."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Karnjanathanalers", "ce:indexed-name": "Karnjanathanalers N."}, {"@seq": "4", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Theeramoke", "ce:indexed-name": "Theeramoke V."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Kongsakon", "ce:indexed-name": "Kongsakon R."}, {"@seq": "6", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Kittiratanapaibool", "ce:indexed-name": "Kittiratanapaibool P."}], "et-al": null}, "ref-sourcetitle": "Clinical Practice Guidelines in Psychiatric Disorders"}}, {"ref-fulltext": "Lam Y-WF, Velligan DI, Ereshefsky L. Intra-individual variability in plasma concentrations as an indicator of adherence in schizophrenia [abstract]. Poster presented at the 42nd Annual Meeting of New Clinical Drug Evaluation Unit (NCDEU) June 10-13, 2002; Boca Raton, FL, USA.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Intra-individual variability in plasma concentrations as an indicator of adherence in schizophrenia [abstract]"}, "refd-itemidlist": {"itemid": {"$": "84962042406", "@idtype": "SGR"}}, "ref-text": "Boca Raton, FL, USA", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.-W.F.", "@_fa": "true", "ce:surname": "Lam", "ce:indexed-name": "Lam Y.-W.F."}, {"@seq": "2", "ce:initials": "D.I.", "@_fa": "true", "ce:surname": "Velligan", "ce:indexed-name": "Velligan D.I."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Ereshefsky", "ce:indexed-name": "Ereshefsky L."}]}, "ref-sourcetitle": "The 42nd Annual Meeting of New Clinical Drug Evaluation Unit (NCDEU) June 10-13"}}, {"ref-fulltext": "Weiden P, Glazer W. Assessment and treatment selection for \"revolving door\" inpatients with schizophrenia. Psychiatr Q. 1997;68:377-92.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Assessment and treatment selection for \"revolving door\" inpatients with schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "0030727332", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "377", "@last": "392"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Weiden", "ce:indexed-name": "Weiden P."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Glazer", "ce:indexed-name": "Glazer W."}]}, "ref-sourcetitle": "Psychiatr Q."}}, {"ref-fulltext": "Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Eng J Med. 2005;353:1209-23.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "25144456112", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "353"}, "pagerange": {"@first": "1209", "@last": "1223"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Lieberman", "ce:indexed-name": "Lieberman J.A."}, {"@seq": "2", "ce:initials": "T.S.", "@_fa": "true", "ce:surname": "Stroup", "ce:indexed-name": "Stroup T.S."}, {"@seq": "3", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "McEvoy", "ce:indexed-name": "McEvoy J.P."}, {"@seq": "4", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Swartz", "ce:indexed-name": "Swartz M.S."}, {"@seq": "5", "ce:initials": "R.A.", "@_fa": "true", "ce:surname": "Rosenheck", "ce:indexed-name": "Rosenheck R.A."}, {"@seq": "6", "ce:initials": "D.O.", "@_fa": "true", "ce:surname": "Perkins", "ce:indexed-name": "Perkins D.O."}], "et-al": null}, "ref-sourcetitle": "N Eng J Med."}}, {"ref-fulltext": "Kane JM. Treatment adherence and long-term outcomes. CNS Spectrums. 2007;12:21-6.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Treatment adherence and long-term outcomes"}, "refd-itemidlist": {"itemid": {"$": "36049012418", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "21", "@last": "26"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Kane", "ce:indexed-name": "Kane J.M."}]}, "ref-sourcetitle": "CNS Spectrums."}}, {"ref-fulltext": "Morken G, Widen JH, Grawe RW. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry. 2008;8:32.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "44249114045", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "32"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Morken", "ce:indexed-name": "Morken G."}, {"@seq": "2", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Widen", "ce:indexed-name": "Widen J.H."}, {"@seq": "3", "ce:initials": "R.W.", "@_fa": "true", "ce:surname": "Grawe", "ce:indexed-name": "Grawe R.W."}]}, "ref-sourcetitle": "BMC Psychiatry"}}, {"ref-fulltext": "Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-24.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Combination of direct and indirect evidence in mixed treatment comparisons"}, "refd-itemidlist": {"itemid": {"$": "5044221416", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "3105", "@last": "3124"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Lu", "ce:indexed-name": "Lu G."}, {"@seq": "2", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Ades", "ce:indexed-name": "Ades A.E."}]}, "ref-sourcetitle": "Stat Med."}}, {"ref-fulltext": "Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008;11:956-64.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Bayesian meta-analysis of multiple treatment comparisons: An introduction to mixed treatment comparisons"}, "refd-itemidlist": {"itemid": {"$": "52649100566", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "956", "@last": "964"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Jansen", "ce:indexed-name": "Jansen J.P."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Crawford", "ce:indexed-name": "Crawford B."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Bergman", "ce:indexed-name": "Bergman G."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Stam", "ce:indexed-name": "Stam W."}]}, "ref-sourcetitle": "Value Health."}}, {"ref-fulltext": "Leucht S, Cipriani A, Spineli L, Mavridis D, rey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multipletreatments meta-analysis. Lancet. 2013;382:951-62.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multipletreatments meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "84884161208", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "382"}, "pagerange": {"@first": "951", "@last": "962"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Leucht", "ce:indexed-name": "Leucht S."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Cipriani", "ce:indexed-name": "Cipriani A."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Spineli", "ce:indexed-name": "Spineli L."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Mavridis", "ce:indexed-name": "Mavridis D."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Rey", "ce:indexed-name": "Rey D."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Richter", "ce:indexed-name": "Richter F."}], "et-al": null}, "ref-sourcetitle": "Lancet."}}, {"ref-fulltext": "Ades AE, Mavranezouli I, Dias S, Welton NJ, Whittington C, Kendall T. Network meta-analysis with competing risk outcomes. Value Health. 2010;13:976-83.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Network meta-analysis with competing risk outcomes"}, "refd-itemidlist": {"itemid": {"$": "78650107453", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "976", "@last": "983"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Ades", "ce:indexed-name": "Ades A.E."}, {"@seq": "2", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Mavranezouli", "ce:indexed-name": "Mavranezouli I."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Dias", "ce:indexed-name": "Dias S."}, {"@seq": "4", "ce:initials": "N.J.", "@_fa": "true", "ce:surname": "Welton", "ce:indexed-name": "Welton N.J."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Whittington", "ce:indexed-name": "Whittington C."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Kendall", "ce:indexed-name": "Kendall T."}]}, "ref-sourcetitle": "Value Health"}}, {"ref-fulltext": "Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Assessing the quality of reports of randomized clinical trials: Is blinding necessary?"}, "refd-itemidlist": {"itemid": {"$": "0029914622", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "1", "@last": "12"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.R.", "@_fa": "true", "ce:surname": "Jadad", "ce:indexed-name": "Jadad A.R."}, {"@seq": "2", "ce:initials": "R.A.", "@_fa": "true", "ce:surname": "Moore", "ce:indexed-name": "Moore R.A."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Carroll", "ce:indexed-name": "Carroll D."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Jenkinson", "ce:indexed-name": "Jenkinson C."}, {"@seq": "5", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Reynolds", "ce:indexed-name": "Reynolds D.J."}, {"@seq": "6", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Gavaghan", "ce:indexed-name": "Gavaghan D.J."}], "et-al": null}, "ref-sourcetitle": "Control Clin Trials"}}, {"ref-fulltext": "Dias S, Welton NJ, Sutton AJ, Ades A. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network metaanalysis of randomised controlled trials. [On line]. 2011 [last updated April 2012; cited 2015 October 31]. 2011;20111893, Available from http://www.nicedsu.org.uk; http://research-information. bristol.ac.uk/files/7215331 TSD2-General-meta-analysis.final. 08.05.12.pdf", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-website": {"ce:e-address": {"$": "http://www.nicedsu.org.uk;", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "80052232844", "@idtype": "SGR"}}, "ref-text": "last updated April 2012; cited 2015 October 31. 2011;20111893, http://research-information. bristol.ac.uk/files/7215331 TSD2-General-meta-analysis.final. 08.05.12.pdf", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Dias", "ce:indexed-name": "Dias S."}, {"@seq": "2", "ce:initials": "N.J.", "@_fa": "true", "ce:surname": "Welton", "ce:indexed-name": "Welton N.J."}, {"@seq": "3", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Sutton", "ce:indexed-name": "Sutton A.J."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Ades", "ce:indexed-name": "Ades A."}]}, "ref-sourcetitle": "NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Metaanalysis of Randomised Controlled Trials"}}, {"ref-fulltext": "Welton NJ, Sutton AJ, Cooper N, Abrams KR, Ades AE. Evidence synthesis for decision making in healthcare. Statistics in Practice (series), volume 126. Hoboken: Wiley; 2012.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Evidence synthesis for decision making in healthcare"}, "refd-itemidlist": {"itemid": {"$": "84954293158", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "126"}}, "ref-text": "Hoboken: Wiley", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.J.", "@_fa": "true", "ce:surname": "Welton", "ce:indexed-name": "Welton N.J."}, {"@seq": "2", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Sutton", "ce:indexed-name": "Sutton A.J."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Cooper", "ce:indexed-name": "Cooper N."}, {"@seq": "4", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Abrams", "ce:indexed-name": "Abrams K.R."}, {"@seq": "5", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Ades", "ce:indexed-name": "Ades A.E."}]}, "ref-sourcetitle": "Statistics in Practice (series)"}}, {"ref-fulltext": "Hirsch SR, Gaind R, Rohde PD, Stevens BC, Wing JK. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial, report to the Medical Research Council Committee on Clinical Trials in Psychiatry. BMJ. 1973;1:633-7.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "1973"}, "ref-title": {"ref-titletext": "Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: Double-blind placebo trial, report to the Medical Research Council Committee on Clinical Trials in Psychiatry"}, "refd-itemidlist": {"itemid": {"$": "0015928215", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "1"}, "pagerange": {"@first": "633", "@last": "637"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Hirsch", "ce:indexed-name": "Hirsch S.R."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Gaind", "ce:indexed-name": "Gaind R."}, {"@seq": "3", "ce:initials": "P.D.", "@_fa": "true", "ce:surname": "Rohde", "ce:indexed-name": "Rohde P.D."}, {"@seq": "4", "ce:initials": "B.C.", "@_fa": "true", "ce:surname": "Stevens", "ce:indexed-name": "Stevens B.C."}, {"@seq": "5", "ce:initials": "J.K.", "@_fa": "true", "ce:surname": "Wing", "ce:indexed-name": "Wing J.K."}]}, "ref-sourcetitle": "BMJ"}}, {"ref-fulltext": "Odejide OA, Aderounmu AF. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients. J Clin Psychiatry. 1982;43:195-6.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "1982"}, "ref-title": {"ref-titletext": "Double-blind placebo substitution: Withdrawal of fluphenazine decanoate in schizophrenic patients"}, "refd-itemidlist": {"itemid": {"$": "0020052478", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "43"}, "pagerange": {"@first": "195", "@last": "196"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "O.A.", "@_fa": "true", "ce:surname": "Odejide", "ce:indexed-name": "Odejide O.A."}, {"@seq": "2", "ce:initials": "A.F.", "@_fa": "true", "ce:surname": "Aderounmu", "ce:indexed-name": "Aderounmu A.F."}]}, "ref-sourcetitle": "J Clin Psychiatry"}}, {"ref-fulltext": "Sampath G, Shah A, Krska J, Soni SD. Neuroleptic discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levels. Hum Psychopharmacol. 1992;7:255-64.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Neuroleptic discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levels"}, "refd-itemidlist": {"itemid": {"$": "0026497409", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "255", "@last": "264"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Sampath", "ce:indexed-name": "Sampath G."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Shah", "ce:indexed-name": "Shah A."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Krska", "ce:indexed-name": "Krska J."}, {"@seq": "4", "ce:initials": "S.D.", "@_fa": "true", "ce:surname": "Soni", "ce:indexed-name": "Soni S.D."}]}, "ref-sourcetitle": "Hum Psychopharmacol"}}, {"ref-fulltext": "Eberhard G, Hellbom E. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison. Acta Psychiatr Scand. 1986;74:255-62.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "1986"}, "ref-title": {"ref-titletext": "Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison"}, "refd-itemidlist": {"itemid": {"$": "0023035629", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "74"}, "pagerange": {"@first": "255", "@last": "262"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Eberhard", "ce:indexed-name": "Eberhard G."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Hellbom", "ce:indexed-name": "Hellbom E."}]}, "ref-sourcetitle": "Acta Psychiatr Scand."}}, {"ref-fulltext": "Chouinard G, Annable L, Campbell W. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. J Clin Psychopharmacol. 1989;9:247-53.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "1989"}, "ref-title": {"ref-titletext": "A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "0024364402", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "247", "@last": "253"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Chouinard", "ce:indexed-name": "Chouinard G."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Annable", "ce:indexed-name": "Annable L."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Campbell", "ce:indexed-name": "Campbell W."}]}, "ref-sourcetitle": "J Clin Psychopharmacol."}}, {"ref-fulltext": "Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J. A double-blind controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. In: Pichot P, editor. Psychiatry: the state of the art. Proceedings of the 7th World Congress of Psychiatry, held July 11-16, 1983, in Vienna, Austria, 3rd Edition. New York: Plenum Press; 1985, p. 759-61.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "1983", "@last": "1985"}, "ref-title": {"ref-titletext": "A double-blind controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "84962071913", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "759", "@last": "761"}}, "ref-text": "Pichot P, editor, held July 11-16, in Vienna, Austria, 3rd Edition. New York: Plenum Press", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Chouinard", "ce:indexed-name": "Chouinard G."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Annable", "ce:indexed-name": "Annable L."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Campbell", "ce:indexed-name": "Campbell W."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Boisvert", "ce:indexed-name": "Boisvert D."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Bradwejn", "ce:indexed-name": "Bradwejn J."}]}, "ref-sourcetitle": "Psychiatry: The State of the Art. Proceedings of the 7th World Congress of Psychiatry"}}, {"ref-fulltext": "Cookson JC, Kennedy NM, Gribbon D. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate. Int Clin Psychopharmacol. 1986;1(Suppl. 1):41-51.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "1986"}, "ref-title": {"ref-titletext": "Weight gain and prolactin levels in patients on long-term antipsychotic medication: A double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate"}, "refd-itemidlist": {"itemid": {"$": "0022740566", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "1"}, "pagerange": {"@first": "41", "@last": "51"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Cookson", "ce:indexed-name": "Cookson J.C."}, {"@seq": "2", "ce:initials": "N.M.", "@_fa": "true", "ce:surname": "Kennedy", "ce:indexed-name": "Kennedy N.M."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Gribbon", "ce:indexed-name": "Gribbon D."}]}, "ref-sourcetitle": "Int Clin Psychopharmacol."}}, {"ref-fulltext": "Jolley AG, Hirsch SR, Morrison E, McRink A, Wilson L. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years. BMJ. 1990;301:837-42.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "1990"}, "ref-title": {"ref-titletext": "Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: Clinical and social outcome at two years"}, "refd-itemidlist": {"itemid": {"$": "0025119859", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "301"}, "pagerange": {"@first": "837", "@last": "842"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.G.", "@_fa": "true", "ce:surname": "Jolley", "ce:indexed-name": "Jolley A.G."}, {"@seq": "2", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Hirsch", "ce:indexed-name": "Hirsch S.R."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Morrison", "ce:indexed-name": "Morrison E."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "McRink", "ce:indexed-name": "McRink A."}, {"@seq": "5", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Wilson", "ce:indexed-name": "Wilson L."}]}, "ref-sourcetitle": "BMJ"}}, {"ref-fulltext": "Jolley AG, Hirsch SR, McRink A, Manchanda R. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. BMJ. 1989;298:985-90.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "1989"}, "ref-title": {"ref-titletext": "Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: Clinical outcome at one year"}, "refd-itemidlist": {"itemid": {"$": "0024591647", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "298"}, "pagerange": {"@first": "985", "@last": "990"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.G.", "@_fa": "true", "ce:surname": "Jolley", "ce:indexed-name": "Jolley A.G."}, {"@seq": "2", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Hirsch", "ce:indexed-name": "Hirsch S.R."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "McRink", "ce:indexed-name": "McRink A."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Manchanda", "ce:indexed-name": "Manchanda R."}]}, "ref-sourcetitle": "BMJ"}}, {"ref-fulltext": "Kissling W, Moller HJ, Walter K, Wittmann B, Krueger R, Trenk D. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention. Pharmacopsychiatry. 1985;18:240-5.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "1985"}, "ref-title": {"ref-titletext": "Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention"}, "refd-itemidlist": {"itemid": {"$": "0021809467", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "240", "@last": "245"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Kissling", "ce:indexed-name": "Kissling W."}, {"@seq": "2", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Moller", "ce:indexed-name": "Moller H.J."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Walter", "ce:indexed-name": "Walter K."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wittmann", "ce:indexed-name": "Wittmann B."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Krueger", "ce:indexed-name": "Krueger R."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Trenk", "ce:indexed-name": "Trenk D."}]}, "ref-sourcetitle": "Pharmacopsychiatry"}}, {"ref-fulltext": "McKane JP, Robinson AD, Wiles DH, McCreadie RG, Stirling GS. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients. Br J Psychiatry. 1987;151:333-6.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "1987"}, "ref-title": {"ref-titletext": "Haloperidol decanoate v. Fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients"}, "refd-itemidlist": {"itemid": {"$": "0023229949", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "151"}, "pagerange": {"@first": "333", "@last": "336"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "McKane", "ce:indexed-name": "McKane J.P."}, {"@seq": "2", "ce:initials": "A.D.", "@_fa": "true", "ce:surname": "Robinson", "ce:indexed-name": "Robinson A.D."}, {"@seq": "3", "ce:initials": "D.H.", "@_fa": "true", "ce:surname": "Wiles", "ce:indexed-name": "Wiles D.H."}, {"@seq": "4", "ce:initials": "R.G.", "@_fa": "true", "ce:surname": "McCreadie", "ce:indexed-name": "McCreadie R.G."}, {"@seq": "5", "ce:initials": "G.S.", "@_fa": "true", "ce:surname": "Stirling", "ce:indexed-name": "Stirling G.S."}]}, "ref-sourcetitle": "Br J Psychiatry"}}, {"ref-fulltext": "Sharma SK, Jaigirdar SH. A comparison of fluphenazine decanoate and haloperidol decanoate in chronic schizophrenia. Br J Clin Res. 1991;2:177-86.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "1991"}, "ref-title": {"ref-titletext": "A comparison of fluphenazine decanoate and haloperidol decanoate in chronic schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "84962122592", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "177", "@last": "186"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.K.", "@_fa": "true", "ce:surname": "Sharma", "ce:indexed-name": "Sharma S.K."}, {"@seq": "2", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Jaigirdar", "ce:indexed-name": "Jaigirdar S.H."}]}, "ref-sourcetitle": "Br J Clin Res."}}, {"ref-fulltext": "Fleischhacker WW, Gopal S, Lane R, Gassmann-Mayer C, Lim P, Hough D, et al. A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia. Int J Neuropsychopharmacol. 2012;15:107-18.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "84856410097", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "107", "@last": "118"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.W.", "@_fa": "true", "ce:surname": "Fleischhacker", "ce:indexed-name": "Fleischhacker W.W."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gopal", "ce:indexed-name": "Gopal S."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Lane", "ce:indexed-name": "Lane R."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Gassmann-Mayer", "ce:indexed-name": "Gassmann-Mayer C."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim P."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Hough", "ce:indexed-name": "Hough D."}], "et-al": null}, "ref-sourcetitle": "Int J Neuropsychopharmacol."}}, {"ref-fulltext": "Hough D, Gopal S, Vijapurkar U, Lim P, Morozova M, Eerdekens M. Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res. 2010;116:107-17.", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study"}, "refd-itemidlist": {"itemid": {"$": "74449091850", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "116"}, "pagerange": {"@first": "107", "@last": "117"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Hough", "ce:indexed-name": "Hough D."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gopal", "ce:indexed-name": "Gopal S."}, {"@seq": "3", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Vijapurkar", "ce:indexed-name": "Vijapurkar U."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim P."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Morozova", "ce:indexed-name": "Morozova M."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Eerdekens", "ce:indexed-name": "Eerdekens M."}]}, "ref-sourcetitle": "Schizophr Res."}}, {"ref-fulltext": "Pinto R, Bannerjee A, Ghosh N. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia. Acta Psychiat Scand. 1979;60:313-22.", "@id": "38", "ref-info": {"ref-publicationyear": {"@first": "1979"}, "ref-title": {"ref-titletext": "A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia"}, "refd-itemidlist": {"itemid": {"$": "0018670844", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "60"}, "pagerange": {"@first": "313", "@last": "322"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Pinto", "ce:indexed-name": "Pinto R."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bannerjee", "ce:indexed-name": "Bannerjee A."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ghosh", "ce:indexed-name": "Ghosh N."}]}, "ref-sourcetitle": "Acta Psychiat Scand."}}, {"ref-fulltext": "Wistedt B, Ranta J. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology. Acta Psychiat Scand. 1983;67:378-88.", "@id": "39", "ref-info": {"ref-publicationyear": {"@first": "1983"}, "ref-title": {"ref-titletext": "Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology"}, "refd-itemidlist": {"itemid": {"$": "0020504949", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "67"}, "pagerange": {"@first": "378", "@last": "388"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wistedt", "ce:indexed-name": "Wistedt B."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ranta", "ce:indexed-name": "Ranta J."}]}, "ref-sourcetitle": "Acta Psychiat Scand."}}, {"ref-fulltext": "Wistedt B, Koskinen T, Thelander S, Nerdrum T, Pedersen V, Mlbjerg C. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study. Acta Psychiat Scand. 1991;84:14-21.", "@id": "40", "ref-info": {"ref-publicationyear": {"@first": "1991"}, "ref-title": {"ref-titletext": "Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: A double-blind multicentre study"}, "refd-itemidlist": {"itemid": {"$": "0025743253", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "84"}, "pagerange": {"@first": "14", "@last": "21"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wistedt", "ce:indexed-name": "Wistedt B."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Koskinen", "ce:indexed-name": "Koskinen T."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Thelander", "ce:indexed-name": "Thelander S."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Nerdrum", "ce:indexed-name": "Nerdrum T."}, {"@seq": "5", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Pedersen", "ce:indexed-name": "Pedersen V."}, {"@seq": "6", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Mlbjerg", "ce:indexed-name": "Mlbjerg C."}]}, "ref-sourcetitle": "Acta Psychiat Scand."}}, {"ref-fulltext": "Eklund K, Forsman A. Minimal effective dose and relapse-double-blind trial: haloperidol decanoate vs. placebo. Clin Neuropharmacol. 1991;14(Suppl. 2):S7-12; discussion S12-15.", "@id": "41", "ref-info": {"ref-publicationyear": {"@first": "1991"}, "ref-title": {"ref-titletext": "Minimal effective dose and relapse-double-blind trial: Haloperidol decanoate vs. Placebo"}, "refd-itemidlist": {"itemid": {"$": "0026002768", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "S7", "@last": "S12"}}, "ref-text": "discussion S12-15", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Eklund", "ce:indexed-name": "Eklund K."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Forsman", "ce:indexed-name": "Forsman A."}]}, "ref-sourcetitle": "Clin Neuropharmacol."}}, {"ref-fulltext": "Dencker SJ, Lepp M, Malm U. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate. Acta Psychiat Scand Suppl. 1980;279:10-28.", "@id": "42", "ref-info": {"ref-publicationyear": {"@first": "1980"}, "ref-title": {"ref-titletext": "Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate"}, "refd-itemidlist": {"itemid": {"$": "0018907042", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "279"}, "pagerange": {"@first": "10", "@last": "28"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Dencker", "ce:indexed-name": "Dencker S.J."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lepp", "ce:indexed-name": "Lepp M."}, {"@seq": "3", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Malm", "ce:indexed-name": "Malm U."}]}, "ref-sourcetitle": "Acta Psychiat Scand Suppl."}}, {"ref-fulltext": "Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379:2063-71.", "@id": "43", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "84861585734", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "379"}, "pagerange": {"@first": "2063", "@last": "2071"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Leucht", "ce:indexed-name": "Leucht S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Tardy", "ce:indexed-name": "Tardy M."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Komossa", "ce:indexed-name": "Komossa K."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Heres", "ce:indexed-name": "Heres S."}, {"@seq": "5", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Kissling", "ce:indexed-name": "Kissling W."}, {"@seq": "6", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Salanti", "ce:indexed-name": "Salanti G."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multipletreatments meta-analysis. Lancet. 2013;382:951-62.", "@id": "44", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multipletreatments meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "84884161208", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "382"}, "pagerange": {"@first": "951", "@last": "962"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Leucht", "ce:indexed-name": "Leucht S."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Cipriani", "ce:indexed-name": "Cipriani A."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Spineli", "ce:indexed-name": "Spineli L."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Mavridis", "ce:indexed-name": "Mavridis D."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Orey", "ce:indexed-name": "Orey D."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Richter", "ce:indexed-name": "Richter F."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Kishimoto T, Robenzadeh A, Leucht C, Leucht S, Watanabe K, Mimura M, et al. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophrenia Bull. 2014;40:192-213.", "@id": "45", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: A meta-analysis of randomized trials"}, "refd-itemidlist": {"itemid": {"$": "84892639627", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "192", "@last": "213"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Kishimoto", "ce:indexed-name": "Kishimoto T."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Robenzadeh", "ce:indexed-name": "Robenzadeh A."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Leucht", "ce:indexed-name": "Leucht C."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Leucht", "ce:indexed-name": "Leucht S."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe K."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Mimura", "ce:indexed-name": "Mimura M."}], "et-al": null}, "ref-sourcetitle": "Schizophrenia Bull."}}, {"ref-fulltext": "Woods BS, Hawkins N, Scott DA. Network metaanalysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC. 2010;10:54.", "@id": "46", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Network metaanalysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial"}, "refd-itemidlist": {"itemid": {"$": "77953235448", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "54"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.S.", "@_fa": "true", "ce:surname": "Woods", "ce:indexed-name": "Woods B.S."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Hawkins", "ce:indexed-name": "Hawkins N."}, {"@seq": "3", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Scott", "ce:indexed-name": "Scott D.A."}]}, "ref-sourcetitle": "BMC"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Tucson", "@id": "60010065", "affilname": "The University of Arizona", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010065", "affiliation-country": "United States"}, {"affiliation-city": "Chiang Mai", "@id": "60000881", "affilname": "Chiang Mai University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "116497145", "affilname": "Medical Affairs", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116497145", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84962109840", "dc:description": "Long-acting injectable antipsychotics (LAIs) are recommended for schizophrenic patients who cannot adhere to oral medication. We systematically reviewed randomized controlled trials of 6 LAIs available in Thailand including fluphenazine, flupentixol, haloperidol, zuclopenthixol, paliperidone, and risperidone in PubMed/MEDLINE and the Cochrane library (1955-Nov 2013). Inclusion was limited to studies of schizophrenia \u226524 weeks duration published in English. We selected 17 of 1,245 articles including 1,904 patients. The number of patients ranged from 19 to 747 per study (median 54). Mean study duration was 52.3 weeks (24-96 weeks) and median quality score using a Jadad scoring method was 4 (2-5). We applied a Bayesian model with a mixed treatment comparison approach for 3 competing risk outcomes including relapse, and discontinuation because of adverse events or other reasons. Based on the random effect model preferred by a goodness of fit analysis, risperidone had the lowest 52 week probability of relapse (mean \u00b1 SD, 0.26 \u00b1 0.321) followed by paliperidone (0.30 \u00b1 0.314). Zuclopenthixol had the lowest probability of discontinuation because of an adverse event (0.07 \u00b1 0.159) or other reasons (0.26 \u00b1 0.295). Risperidone had the highest probability of preventing relapse (0.35 \u00b1 0.476) or discontinuation for other reasons (0.31 \u00b1 0.461). Zuclopenthixol had the highest probability of preventing discontinuation because of adverse effects (0.31 \u00b1 0.464). All 6 LAIs tended to have a lower risk of relapse compared with placebo. Differences between LAIs preventing any treatment discontinuation or relapse were seen, but limited in our analysis.", "prism:coverDate": "2015-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84962109840", "dc:creator": {"author": [{"ce:given-name": "Osot", "preferred-name": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}, "@seq": "1", "ce:initials": "O.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "116497145", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116497145"}], "ce:surname": "Nerapusee", "@auid": "37024668000", "author-url": "https://api.elsevier.com/content/author/author_id/37024668000", "ce:indexed-name": "Nerapusee O."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84962109840"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962109840&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84962109840&origin=inward"}], "source-id": "19300156818", "citedby-count": "1", "prism:volume": "9", "subtype": "re", "dc:title": "Long-acting injectable antipsychotics in patients with schizophrenia: Systematic review and mixed treatment meta-analysis", "openaccess": null, "prism:issn": "1875855X 19057415", "prism:issueIdentifier": "6", "subtypeDescription": "Review", "prism:publicationName": "Asian Biomedicine", "prism:pageRange": "741-750", "prism:endingPage": "750", "openaccessFlag": null, "prism:doi": "10.5372/1905-7415.0906.446", "prism:startingPage": "741", "dc:identifier": "SCOPUS_ID:84962109840", "dc:publisher": "Asian Biomedicinechulamed@md.chula.ac.th"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Competing risk outcomes"}, {"@_fa": "true", "$": "Long acting injectable antipsychotics"}, {"@_fa": "true", "$": "Meta-analysis"}, {"@_fa": "true", "$": "Mixed treatment comparison"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Biochemistry, Genetics and Molecular Biology (all)", "@code": "1300", "@abbrev": "BIOC"}]}, "authors": {"author": [{"ce:given-name": "Osot", "preferred-name": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}, "@seq": "1", "ce:initials": "O.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "116497145", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116497145"}], "ce:surname": "Nerapusee", "@auid": "37024668000", "author-url": "https://api.elsevier.com/content/author/author_id/37024668000", "ce:indexed-name": "Nerapusee O."}, {"ce:given-name": "Chanadda", "preferred-name": {"ce:given-name": "Chanadda", "ce:initials": "C.", "ce:surname": "Chinthammit", "ce:indexed-name": "Chinthammit C."}, "@seq": "2", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60010065", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010065"}, "ce:surname": "Chinthammit", "@auid": "55195924000", "author-url": "https://api.elsevier.com/content/author/author_id/55195924000", "ce:indexed-name": "Chinthammit C."}, {"ce:given-name": "Chavalit", "preferred-name": {"ce:given-name": "Chavalit", "ce:initials": "C.", "ce:surname": "Romyen", "ce:indexed-name": "Romyen C."}, "@seq": "3", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "116497145", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116497145"}, "ce:surname": "Romyen", "@auid": "57188648640", "author-url": "https://api.elsevier.com/content/author/author_id/57188648640", "ce:indexed-name": "Romyen C."}, {"ce:given-name": "Maneeporn", "preferred-name": {"ce:given-name": "Maneeporn", "ce:initials": "M.", "ce:surname": "Pangjunhom", "ce:indexed-name": "Pangjunhom M."}, "@seq": "4", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60000881", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"}, "ce:surname": "Pangjunhom", "@auid": "57188654191", "author-url": "https://api.elsevier.com/content/author/author_id/57188654191", "ce:indexed-name": "Pangjunhom M."}, {"ce:given-name": "Daniel C.", "preferred-name": {"ce:given-name": "Daniel C.", "ce:initials": "D.C.", "ce:surname": "Malone", "ce:indexed-name": "Malone D."}, "@seq": "5", "ce:initials": "D.C.", "@_fa": "true", "affiliation": {"@id": "60010065", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010065"}, "ce:surname": "Malone", "@auid": "7102595928", "author-url": "https://api.elsevier.com/content/author/author_id/7102595928", "ce:indexed-name": "Malone D.C."}, {"ce:given-name": "Rungpetch", "preferred-name": {"ce:given-name": "Rungpetch", "ce:initials": "R.", "ce:surname": "Sakulbumrungsil", "ce:indexed-name": "Sakulbumrungsil R."}, "@seq": "6", "ce:initials": "R.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sakulbumrungsil", "@auid": "23089392500", "author-url": "https://api.elsevier.com/content/author/author_id/23089392500", "ce:indexed-name": "Sakulbumrungsil R."}]}}}